Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedFeb 05, 2023
DataAggregated Company Financials
Companies48
  • 7D4.6%
  • 3M21.0%
  • 1Y30.6%
  • YTD1.3%

Over the last 7 days, the Pharma industry has remained flat. As for the the longer term, the industry is up 25% over the past 12 months. Earnings are forecast to grow by 42% annually.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Feb 2023NT$507.8bNT$84.6bNT$7.9b21x64.4x6x
Tue, 03 Jan 2023NT$502.1bNT$84.6bNT$7.9b21.8x63.7x5.9x
Thu, 01 Dec 2022NT$481.8bNT$84.6bNT$7.9b16.2x61.1x5.7x
Sat, 29 Oct 2022NT$389.9bNT$78.9bNT$4.3b17x90.1x4.9x
Mon, 26 Sep 2022NT$451.2bNT$78.9bNT$4.3b18x104.3x5.7x
Wed, 24 Aug 2022NT$444.1bNT$78.9bNT$4.3b18.2x102.5x5.6x
Fri, 22 Jul 2022NT$385.5bNT$76.7bNT$4.4b21.3x86.7x5x
Sun, 19 Jun 2022NT$396.2bNT$76.8bNT$4.4b21.5x90.7x5.2x
Tue, 17 May 2022NT$369.5bNT$76.0bNT$4.1b19.9x90.7x4.9x
Thu, 14 Apr 2022NT$404.6bNT$76.6bNT$6.6b21.1x61.5x5.3x
Sat, 12 Mar 2022NT$380.8bNT$76.7bNT$8.5b20.5x44.6x5x
Mon, 07 Feb 2022NT$379.4bNT$76.7bNT$8.5b18.9x44.8x4.9x
Wed, 05 Jan 2022NT$386.7bNT$76.7bNT$8.5b18.5x45.7x5x
Fri, 03 Dec 2021NT$384.1bNT$76.7bNT$8.5b17.6x45.4x5x
Sun, 31 Oct 2021NT$377.1bNT$76.0bNT$10.4b17.6x36.1x5x
Tue, 28 Sep 2021NT$357.8bNT$76.0bNT$10.7b19.1x33.3x4.7x
Thu, 26 Aug 2021NT$354.1bNT$76.0bNT$10.7b20x33x4.7x
Fri, 02 Jul 2021NT$369.1bNT$76.0bNT$10.7b19.1x34.4x4.9x
Mon, 05 Apr 2021NT$363.3bNT$74.2bNT$12.5b19.4x29x4.9x
Thu, 07 Jan 2021NT$343.5bNT$72.1bNT$8.4b18.5x40.7x4.8x
Wed, 30 Sep 2020NT$376.4bNT$71.7bNT$6.5b18.6x58x5.2x
Sat, 04 Jul 2020NT$363.6bNT$70.9bNT$5.6b22.4x64.7x5.1x
Tue, 07 Apr 2020NT$190.1bNT$70.2bNT$1.8b21.4x103.6x2.7x
Price to Earnings Ratio

180.8x


Total Market Cap: NT$226.6bTotal Earnings: NT$1.3bTotal Revenue: NT$69.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 65.5x202120222023
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 61.4x which is lower than its 3-year average PE of 68.5x.
  • The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 85% per year over the last three years.
  • Revenues for these companies have grown 6.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market4.62%
Healthcare5.77%
Pharma4.59%
Pharma4.59%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4743 Oneness BiotechNT$263.007.6%
+NT$7.2b
10.0%PE90.7x
6586 CHO PharmaNT$138.0015.0%
+NT$3.3b
-7.4%PS7111.5x
6620 Handa PharmaceuticalsNT$138.0016.9%
+NT$2.6b
161.4%PS318.2x
1795 Lotus PharmaceuticalNT$249.002.3%
+NT$1.4b
190.5%PE21x
4123 Center LaboratoriesNT$48.405.2%
+NT$1.4b
-3.7%PS44.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4743

NT$263.00

Oneness Biotech

7D

7.6%

1Y

10.0%

4119

NT$98.00

SCI Pharmtech

7D

-0.1%

1Y

19.1%

4114

NT$43.40

Synmosa Biopharma

7D

-3.1%

1Y

105.1%

6576

NT$105.50

Foresee Pharmaceuticals

7D

11.4%

1Y

-7.9%

1795

NT$249.00

Lotus Pharmaceutical

7D

2.3%

1Y

190.5%

1701

NT$27.05

China Chemical & Pharmaceutical

7D

-0.7%

1Y

24.4%

4123

NT$48.40

Center Laboratories

7D

5.2%

1Y

-3.7%

1760

NT$173.50

Panion & Bf Biotech

7D

5.2%

1Y

111.6%

6620

NT$138.00

Handa Pharmaceuticals

7D

16.9%

1Y

161.4%

6586

NT$138.00

CHO Pharma

7D

15.0%

1Y

-7.4%

4120

NT$35.85

Orient EuroPharma

7D

-0.1%

1Y

11.0%

1789

NT$26.55

ScinoPharm Taiwan

7D

4.5%

1Y

13.9%

4172

NT$12.00

InnoPharmax

7D

-0.4%

1Y

-33.5%

6676

NT$18.40

Sunny Pharmtech

7D

-0.3%

1Y

-20.0%

6652

NT$7.01

Eusol BiotechLtd

7D

-3.0%

1Y

-41.6%

6634

NT$102.00

Sinew Pharma

7D

-0.5%

1Y

20.0%